The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Du, Tao ^a,b   Zhu, Ying Jian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; SELECTIN;

ACUTE KIDNEY FAILURE; DENDRITIC CELL; HUMAN; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; REVIEW; TISSUE REPAIR; ACUTE KIDNEY INJURY; ANIMAL; IMMUNOLOGY; KIDNEY; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; CHEMOKINES; CYTOKINES; HUMANS; INFLAMMATION; KIDNEY; MESENCHYMAL STROMAL CELLS;

EID: 84899950777     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/261697     Document Type: Review

References (124)

1. Legrand M., Mik E. G., Johannes T., Payen D., Ince C., Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Molecular Medicine 2008 14 7-8 502 516 2-s2.0-48149111863 10.2119/2008-00006.Legrand
2. Bellomo R., Wan L., Langenberg C., May C., Septic acute kidney injury: new concepts. Nephron: Experimental Nephrology 2008 109 4 e95 e100 2-s2.0-52449100033 10.1159/000142933
3. Pannu N., Nadim M. K., An overview of drug-induced acute kidney injury. Critical Care Medicine 2008 36 4 S216 S223 2-s2.0-41649087623 10.1097/CCM.0b013e318168e375 (Pubitemid 351483055)
4. Bonventre J. V., Yang L., Cellular pathophysiology of ischemic acute kidney injury. The Journal of Clinical Investigation 2011 121 11 4210 4221 2-s2.0-80555157523 10.1172/JCI45161
5. Bonventre J. V., Zuk A., Ischemic acute renal failure: an inflammatory disease? Kidney International 2004 66 2 480 485 2-s2.0-3242772187 10.1111/j.1523-1755.2004.761-2.x (Pubitemid 38981982)
6. Friedewald J. J., Rabb H., Inflammatory cells in ischemic acute renal failure. Kidney International 2004 66 2 486 491 2-s2.0-3242806045 10.1111/j.1523-1755.2004.761-3.x (Pubitemid 38981983)
7. 3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. Immunology and Cell Biology 2001 79 3 298 302 2-s2.0-0034743823 10.1046/j.1440-1711.2001. 01004.x (Pubitemid 32522179)
8. Rodríguez-Iturbe B., García G. G., The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron: Clinical Practice 2010 116 2 81 88 10.1159/000314656
9. Yalavanthy R., Edelstein C. L., Therapeutic and predictive targets of AKI. Clinical Nephrology 2008 70 6 453 463 2-s2.0-57349151138
10. Malgieri A., Kantzari E., Patrizi M. P., Gambardella S., Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. International Journal of Clinical and Experimental Medicine 2010 3 4 248 269 2-s2.0-78649733250
11. Gao J., Liu R., Wu J., Liu Z., Li J., Zhou J., Hao T., Wang Y., Du Z., Duan C., Wang C., The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury. Biomaterials 2012 33 14 3673 3681 2-s2.0-84857794920 10.1016/j.biomaterials. 2012.01.061
12. Zhu S. F., Zhong Z. N., Fu X. F., Comparison of cell proliferation, apoptosis, cellular morphology and ultrastructure between human umbilical cord and placenta-derived mesenchymal stem cells. Neuroscience Letters 2013 541 77 82 10.1016/j.neulet.2013.03.018
13. Jones B. A., Pei M., Synovium-derived stem cells: a tissue-specific stem cell for cartilage engineering and regeneration. Tissue Engineering B: Reviews 2012 18 4 301 311 10.1089/ten.teb.2012.0002
14. Tamaki T., Soeda S., Hashimoto H., 3D reconstitution of nerve-blood vessel networks using skeletal muscle-derived multipotent stem cell sheet pellets. Regenerative Medicine 2013 8 4 437 451
15. Dominici M., le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F. C., Krause D. S., Deans R. J., Keating A., Prockop D. J., Horwitz E. M., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006 8 4 315 317 2-s2.0-33747713246 10.1080/14653240600855905 (Pubitemid 44269669)
16. Tögel F., Weiss K., Yang Y., Hu Z., Zhang P., Westenfelder C., Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. American Journal of Physiology: Renal Physiology 2007 292 5 F1626 F1635 2-s2.0-34247854809 10.1152/ajprenal.00339. 2006 (Pubitemid 46701891)
17. Cheng K., Rai P., Plagov A., Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms. Experimental and Molecular Pathology 2013 94 3 466 473
18. Tögel F., Hu Z., Weiss K., Isaac J., Lange C., Westenfelder C., Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. American Journal of Physiology: Renal Physiology 2005 289 1 F31 F42 2-s2.0-20844440562 10.1152/ajprenal.00007. 2005 (Pubitemid 40863570)
19. Eliopoulos N., Zhao J., Bouchentouf M., Forner K., Birman E., Yuan S., Boivin M.-N., Martineau D., Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection. American Journal of Physiology: Renal Physiology 2010 299 6 F1288 F1298 2-s2.0-78649947922 10.1152/ajprenal.00671.2009
20. Luo C. J., Zhang F. J., Zhang L., Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Shock 2014 41 2 123 129 10.1097/SHK.0000000000000080
21. Furuichi K., Shintani H., Sakai Y., Ochiya T., Matsushima K., Kaneko S., Wada T., Effects of adipose-derived mesenchymal cells on ischemia-reperfusion injury in kidney. Clinical and Experimental Nephrology 2012 16 5 679 689 2-s2.0-84857700068 10.1007/s10157-012-0614-6
22. Tsuda H., Yamahara K., Otani K., Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protect against ischemia-reperfusion- induced acute kidney injury. Cell Transplantation. In press
23. Semedo P., Palasio C. G., Oliveira C. D., Feitoza C. Q., Gonçalves G. M., Cenedeze M. A., Wang P. M. H., Teixeira V. P. A., Reis M. A., Pacheco-Silva A., Câmara N. O. S., Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. International Immunopharmacology 2009 9 6 677 682 2-s2.0-65349189919 10.1016/j.intimp.2008.12. 008
24. Cao H. L., Qian H., Xu W. R., Zhu W., Zhang X., Chen Y., Wang M., Yan Y., Xie Y., Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats. Biotechnology Letters 2010 32 5 725 732 2-s2.0-77952238570 10.1007/s10529-010-0207-y
25. Semedo P., Wang P. M., Andreucci T. H., Cenedeze M. A., Teixeira V. P. A., Reis M. A., Pacheco-Silva A., Câmara N. O. S., Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. Transplantation Proceedings 2007 39 2 421 423 2-s2.0-33847716669 10.1016/j.transproceed.2007.01.036 (Pubitemid 46386253)
26. Reis L. A., Borges F. T., Simões M. J., Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. PLoS ONE 2012 7 9, article e44092 10.1371/journal.pone.0044092
27. Du T., Cheng J., Zhong L., The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism. Cytotherapy 2012 14 10 1215 1227 10.3109/14653249.2012.711471
28. Chen Y.-T., Sun C.-K., Lin Y.-C., Chang L.-T., Chen Y.-L., Tsai T.-H., Chung S.-Y., Chua S., Kao Y.-H., Yen C.-H., Shao P.-L., Chang K.-C., Leu S., Yip H.-K., Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. Journal of Translational Medicine 2011 9, article 51 2-s2.0-79955550171 10.1186/1479-5876-9-51
29. Karshovska E., Weber C., von Hundelshausen P., Platelet chemokines in health and disease. Thrombosis and Haemostasis 2013 110 5 894 902 10.1160/TH13-04-0341
30. Imaizumi T., Aizawa-Yashiro T., Tsuruga K., Melanoma differentiation- associated gene 5 regulates the expression of a chemokine CXCL10 in human mesangial cells: implications for chronic inflammatory renal diseases. The Tohoku Journal of Experimental Medicine 2012 228 1 17 26 10.1620/tjem.228.17
31. Furuichi K., Wada T., Yokoyama H., Kobayashi K.-I., Role of cytokines and chemokines in renal ischemia-reperfusion injury. Drug News & Perspectives 2002 15 8 477 482 2-s2.0-0036826384 10.1358/dnp.2002.15.8.840067 (Pubitemid 36227317)
32. Akcay A., Nguyen Q., Edelstein C. L., Mediators of inflammation in acute kidney injury. Mediators of Inflammation 2009 2009 12 2-s2.0-77949397760 10.1155/2009/137072 137072
33. Patel J., Pancholi N., Gudehithlu K. P., Stem cells from foreign body granulation tissue accelerate recovery from acute kidney injury. Nephrology Dialysis Transplantation 2012 27 5 1780 1786 10.1093/ndt/gfr585
34. Faubel S., Lewis E. C., Reznikov L., Ljubanovic D., Hoke T. S., Somerset H., Oh D.-J., Lu L., Klein C. L., Dinarello C. A., Edelstein C. L., Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1 β IL-18, IL-6, and neutrophil infiltration in the kidney. The Journal of Pharmacology and Experimental Therapeutics 2007 322 1 8 15 2-s2.0-34250765336 10.1124/jpet.107.119792 (Pubitemid 46956357)
35. Zhang B., Ramesh G., Uematsu S., Akira S., Reeves W. B., TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. Journal of the American Society of Nephrology 2008 19 5 923 932 2-s2.0-44049103058 10.1681/ASN.2007090982
36. Ramesh G., Reeves W. B., TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. American Journal of Physiology: Renal Physiology 2003 285 4 F610 F618 2-s2.0-0141702103 (Pubitemid 37140245)
37. Goes N., Urmson J., Ramassar V., Halloran P. F., Ischemic acute tubular necrosis induces an extensive local cytokine response: evidence for induction of interferon- γ transforming growth factor- β 1, granulocyte- macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995 59 4 565 572 2-s2.0-0028938713
38. Thurman J. M., Lenderink A. M., Royer P. A., Coleman K. E., Zhou J., Lambris J. D., Nemenoff R. A., Quigg R. J., Holers V. M., C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion. The Journal of Immunology 2007 178 3 1819 1828 2-s2.0-33846495181 (Pubitemid 46154654)
39. Rice J. C., Spence J. S., Yetman D. L., Safirstein R. L., Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney. Renal Failure 2002 24 6 703 723 2-s2.0-0036438153 10.1081/JDI-120015673 (Pubitemid 35404064)
40. Zhao J. J., Liu J. L., Liu L., Jia H. Y., Protection of mesenchymal stem cells on acute kidney injury. Molecular Medicine Reports 2014 9 1 91 96 10.3892/mmr.2013.1792
41. Bi B., Schmitt R., Israilova M., Nishio H., Cantley L. G., Stromal cells protect against acute tubular injury via an endocrine effect. Journal of the American Society of Nephrology 2007 18 9 2486 2496 2-s2.0-34548489620 (Pubitemid 47378865)
42. Imberti B., Morigi M., Tomasoni S., Rota C., Corna D., Longaretti L., Rottoli D., Valsecchi F., Benigni A., Wang J., Abbate M., Zoja C., Remuzzi G., Insulin-like growth factor-1 sustains stem cell-mediated renal repair. Journal of the American Society of Nephrology 2007 18 11 2921 2928 2-s2.0-35848962732 10.1681/ASN.2006121318 (Pubitemid 350058399)
43. Uccelli A., Pistoia V., Moretta L., Mesenchymal stem cells: a new strategy for immunosuppression? Trends in Immunology 2007 28 5 219 226 2-s2.0-34247645621 10.1016/j.it.2007.03.001 (Pubitemid 46667240)
44. Oskowitz A., McFerrin H., Gutschow M., Carter M. L., Pochampally R., Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Research 2011 6 3 215 225 2-s2.0-79954988933 10.1016/j.scr.2011.01.004
45. Qi S., Wu D., Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis. International Journal of Molecular Medicine 2013 32 6 1262 1272 10.3892/ijmm.2013.1517
46. Segerer S., Nelson P. J., Schlondorff D., Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. Journal of the American Society of Nephrology 2000 11 1 152 176 2-s2.0-0033971775 (Pubitemid 30020438)
47. Furuichi K., Kaneko S., Wada T., Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease. Clinical and Experimental Nephrology 2009 13 1 9 14 2-s2.0-59449085356 10.1007/s10157-008-0119-5
48. Togel F., Isaac J., Hu Z. M., Weiss K., Westenfelder C., Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney International 2005 67 5 1772 1784 2-s2.0-17744387942 10.1111/j.1523-1755.2005.00275.x (Pubitemid 40577712)
49. Furuichi K., Wada T., Iwata Y., Sakai N., Yoshimoto K., Kobayashi K.-I., Mukaida N., Matsushima K., Yokoyama H., Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice. Nephrology Dialysis Transplantation 2002 17 3 399 407 2-s2.0-0036199728 (Pubitemid 34211135)
50. Balasubramanian S., Venugopal P., Sundarraj S., Zakaria Z., Majumdar A. S., Ta M., Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells. Cytotherapy 2012 14 1 26 33 2-s2.0-83755188640 10.3109/14653249.2011.605119
51. Hung S.-C., Pochampally R. R., Hsu S.-C., Sanchez C. C., Chen S.-C., Spees J., Prockop D. J., Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS ONE 2007 2 5, article e416 2-s2.0-34548739439 10.1371/journal.pone. 0000416
52. Liu H., Liu S., Li Y., The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/ reperfusion injury. PLoS ONE 2012 7 4, article e34608 10.1371/journal.pone.0034608
53. Honczarenko M., Le Y., Swierkowski M., Ghiran I., Glodek A. M., Silberstein L. E., Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006 24 4 1030 1041 2-s2.0-33745489036 10.1634/stemcells.2005-0319 (Pubitemid 44464736)
54. Kim D. S., Lee M. W., Yoo K. H., Gene expression profiles of human adipose tissue-derived mesenchymal stem cells are modified by cell culture density. PLoS ONE 2014 9 1, article e83363 10.1371/journal.pone.0083363
55. Baek S. J., Kang S. K., Ra J. C., In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors. Experimental & Molecular Medicine 2011 43 10 596 603 2-s2.0-80055062477 10.3858/emm.2011.43.10.069
56. Sordi V., Malosio M. L., Marchesi F., Mercalli A., Melzi R., Giordano T., Belmonte N., Ferrari G., Leone B. E., Bertuzzi F., Zerbini G., Allavena P., Bonifacio E., Piemonti L., Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005 106 2 419 427 2-s2.0-22144491551 10.1182/blood-2004-09-3507 (Pubitemid 40981232)
57. Ponte A. L., Marais E., Gallay N., Langonné A., Delorme B., Hérault O., Charbord P., Domenech J., The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007 25 7 1737 1745 2-s2.0-34547217039 10.1634/stemcells.2007-0054 (Pubitemid 47121852)
58. Ringe J., Strassburg S., Neumann K., Endres M., Notter M., Burmester G.-R., Kaps C., Sittinger M., Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. Journal of Cellular Biochemistry 2007 101 1 135 146 2-s2.0-34247472169 10.1002/jcb.21172 (Pubitemid 46652579)
59. Zhang H., Ning H., Banie L., Wang G., Lin G., Lue T. F., Lin C.-S., Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties. Biochemical and Biophysical Research Communications 2010 402 3 560 564 2-s2.0-78549261017 10.1016/j.bbrc.2010.10.090
60. Fox J. M., Chamberlain G., Ashton B. A., Middleton J., Recent advances into the understanding of mesenchymal stem cell trafficking. British Journal of Haematology 2007 137 6 491 502 2-s2.0-34249290744 10.1111/j.1365-2141.2007. 06610.x (Pubitemid 46817339)
61. Albelda S. M., Smith C. W., Ward P. A., Adhesion molecules and inflammatory injury. The FASEB Journal 1994 8 8 504 512 2-s2.0-0028231065 (Pubitemid 24161123)
62. Molitoris B. A., Marrs J., The role of cell adhesion molecules in ischemic acute renal failure. American Journal of Medicine 1999 106 5 583 592 2-s2.0-0033135667 10.1016/S0002-9343(99)00061-3 (Pubitemid 29231111)
63. Kelly K. J., Williams W. W. Jr., Colvin R. B., Bonventre J. V., Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proceedings of the National Academy of Sciences of the United States of America 1994 91 2 812 816 2-s2.0-0028039822 (Pubitemid 24041492)
64. Kelly K. J., Williams W. W. Jr., Colvin R. B., Meehan S. M., Springer T. A., Gutiérrez-Ramos J.-C., Bonventre J. V., Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. The Journal of Clinical Investigation 1996 97 4 1056 1063 2-s2.0-0030067639 (Pubitemid 26070586)
65. Hara Y., Stolk M., Ringe J., Dehne T., Ladhoff J., Kotsch K., Reutzel-Selke A., Reinke P., Volk H.-D., Seifert M., In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia. Transplant International 2011 24 11 1112 1123 2-s2.0-80053986576 10.1111/j.1432-2277.2011.01328.x
66. Hagiwara M., Shen B., Chao L., Chao J., Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Human Gene Therapy 2008 19 8 807 819 2-s2.0-50649103709 10.1089/hum.2008.016
67. Dragun D., Hoff U., Park J. K., Qun Y., Schneider W., Luft F. C., Haller H., Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. Kidney International 2000 58 5 2166 2177 2-s2.0-0033736388 10.1046/j.1523-1755.2000.00390.x
68. Rüster B., Göttig S., Ludwig R. J., Bistrian R., Müller S., Seifried E., Gille J., Henschler R., Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006 108 12 3938 3944 2-s2.0-33845277598 10.1182/blood-2006-05-025098 (Pubitemid 44864580)
69. de Filippo K., Dudeck A., Hasenberg M., Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 2013 121 24 4930 4937 10.1182/blood-2013-02-486217
70. Yagi H., Soto-Gutierrez A., Navarro-Alvarez N., Nahmias Y., Goldwasser Y., Kitagawa Y., Tilles A. W., Tompkins R. G., Parekkadan B., Yarmush M. L., Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Molecular Therapy 2010 18 10 1857 1864 2-s2.0-77957580211 10.1038/mt.2010.155
71. Morigi M., Rota C., Montemurro T., Montelatici E., lo Cicero V., Imberti B., Abbate M., Zoja C., Cassis P., Longaretti L., Rebulla P., Introna M., Capelli C., Benigni A., Remuzzi G., Lazzari L., Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells 2010 28 3 513 522 2-s2.0-77950557390 10.1002/stem.293
72. Wang Q., Zhu H., Zhou W. G., N-acetylcysteine- pretreated human embryonic mesenchymal stem cell administration protects against bleomycin-induced lung injury. The American Journal of the Medical Sciences 2013 346 2 113 122 10.1097/MAJ.0b013e318266e8d8
73. Rabb H., The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney International 2002 61 6 1935 1946 2-s2.0-0036098822 10.1046/j.1523-1755.2002.00378.x (Pubitemid 34539311)
74. Hu J., Zhang L., Wang N., Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions. Kidney International 2013 84 3 521 531 10.1038/ki.2013.114
75. + regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury. Nephrology Dialysis Transplantation 2011 26 1 111 124 2-s2.0-78650674133 10.1093/ndt/gfq480
76. + regulatory T cells induced by T cell vaccination protect against autoimmune nephritis. Journal of the American Society of Nephrology 2012 23 6 1058 1067 10.1681/ASN.2011090914
77. + regulatory T cells. Hepatobiliary & Pancreatic Diseases International 2008 7 6 608 614 2-s2.0-57849108938
78. Kim J.-A., Hong S., Lee B., Hong J. W., Kwak J.-Y., Cho S., Kim C.-C., The inhibition of T-cells proliferation by mouse mesenchymal stem cells through the induction of p16 INK4A -cyclin D1/cdk4 and p 21 waf1, p 27 kip1 -cyclin E/cdk2 pathways. Cellular Immunology 2007 245 1 16 23 2-s2.0-34248640119 10.1016/j.cellimm.2007.03.003 (Pubitemid 46776638)
79. Nauta A. J., Fibbe W. E., Immunomodulatory properties of mesenchymal stromal cells. Blood 2007 110 10 3499 3506 2-s2.0-36348977575 10.1182/blood-2007-02-069716 (Pubitemid 350159613)
80. Duffy M. M., Pindjakova J., Hanley S. A., McCarthy C., Weidhofer G. A., Sweeney E. M., English K., Shaw G., Murphy J. M., Barry F. P., Mahon B. P., Belton O., Ceredig R., Griffin M. D., Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. European Journal of Immunology 2011 41 10 2840 2851 2-s2.0-80053153051 10.1002/eji.201141499
81. Yañez R., Oviedo A., Aldea M., Bueren J. A., Lamana M. L., Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Experimental Cell Research 2010 316 19 3109 3123 2-s2.0-77958087116 10.1016/j.yexcr.2010.08.008
82. Najar M., Raicevic G., Boufker H. I., Kazan H. F., Bruyn C. D., Meuleman N., Bron D., Toungouz M., Lagneaux L., Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: combined comparison of adipose tissue, Wharton's jelly and bone marrow sources. Cellular Immunology 2010 264 2 171 179 2-s2.0-77955093536 10.1016/j.cellimm.2010.06.006
83. Sakaguchi S., Yamaguchi T., Nomura T., Ono M., Regulatory T cells and immune tolerance. Cell 2008 133 5 775 787 2-s2.0-43949105866 10.1016/j.cell.2008.05.009 (Pubitemid 351707693)
84. Burne-Taney M. J., Ascon D. B., Daniels F., Racusen L., Baldwin W., Rabb H., B cell deficiency confers protection from renal ischemia reperfusion injury. The Journal of Immunology 2003 171 6 3210 3215 2-s2.0-0041832283 (Pubitemid 37093547)
85. Schena F., Gambini C., Gregorio A., Mosconi M., Reverberi D., Gattorno M., Casazza S., Uccelli A., Moretta L., Martini A., Traggiai E., Interferon- γ -dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis & Rheumatism 2010 62 9 2776 2786 2-s2.0-77956371047 10.1002/art.27560
86. Ma X., Che N., Gu Z., Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplantation 2012 22 12 2279 2290 10.3727/096368912X658692
87. Cerwenka A., Lanier L. L., Natural killer cells, viruses and cancer. Nature Reviews Immunology 2001 1 1 41 49 2-s2.0-0035496603 (Pubitemid 33741974)
88. Zhang Z.-X., Wang S., Huang X., Min W.-P., Sun H., Liu W., Garcia B., Jevnikar A. M., NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. The Journal of Immunology 2008 181 11 7489 7498 2-s2.0-58149279515
89. Pradier A., Passweg J., Villard J., Kindler V., Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity. Cell Transplantation 2011 20 5 681 691 2-s2.0-79960004933 10.3727/096368910X536545
90. + regulatory T cells. Stem Cells 2008 26 1 212 222 2-s2.0-38349053355 10.1634/stemcells.2007-0554
91. Ribeiro A., Laranjeira P., Mendes S., Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem Cell Research & Therapy 2013 4 5, article 125 10.1186/scrt336
92. Zhao Z. G., Cao Z., Xu W., Immune protection function of multipotent mesenchymal stromal cells: role of transforming growth factor- β 1. Cancer Investigation 2012 30 9 646 656 10.3109/07357907.2012.721038
93. Nikolic-Paterson D. J., Atkins R. C., The role of macrophages in glomerulonephritis. Nephrology Dialysis Transplantation 2001 16 supplement 5 3 7 2-s2.0-0034872871 (Pubitemid 32750422)
94. Cao Q., Zheng D., Wang Y. P., Harris D. C., Macrophages and dendritic cells for treating kidney disease. Nephron: Experimental Nephrology 2011 117 3 e47 e52 2-s2.0-77956095621 10.1159/000320595
95. Lu H., Huang D., Saederup N., Charo I. F., Ransohoff R. M., Zhou L., Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury. The FASEB Journal 2011 25 1 358 369 2-s2.0-79251585227 10.1096/fj.10-171579
96. Mosser D. M., Edwards J. P., Exploring the full spectrum of macrophage activation. Nature Reviews Immunology 2008 8 12 958 969 2-s2.0-56749174940 10.1038/nri2448
97. Ricardo S. D., van Goor H., Eddy A. A., Macrophage diversity in renal injury and repair. The Journal of Clinical Investigation 2008 118 11 3522 3530 2-s2.0-55849103960 10.1172/JCI36150
98. Anders H.-J., Ryu M., Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney International 2011 80 9 915 925 2-s2.0-80054728443 10.1038/ki.2011.217
99. Luo J., Zhao X., Tan Z., Su Z., Meng F., Zhang M., Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions. Cytotherapy 2013 15 6 649 662 10.1016/j.jcyt.2013.01.009
100. Lee S., Huen S., Nishio H., Nishio S., Lee H. K., Choi B.-S., Ruhrberg C., Cantley L. G., Distinct macrophage phenotypes contribute to kidney injury and repair. Journal of the American Society of Nephrology 2011 22 2 317 326 2-s2.0-79551654684 10.1681/ASN.2009060615
101. Li W., Zhang Q., Wang M., Macrophages are involved in the protective role of human umbilical cord-derived stromal cells in renal ischemia-reperfusion injury. Stem Cell Research 2013 10 3 405 416 10.1016/j.scr.2013.01.005
102. Okusa M. D., Li L., Dendritic cells in acute kidney injury: cues from the microenvironment. Transactions of the American Clinical and Climatological Association 2012 123 54 62
103. + cells partially mediate the renoprotective effect induced by bone marrow-derived mesenchymal stem cells. PLoS ONE 2013 8 8, article e72544 10.1371/journal.pone.0072544
104. Zhang Y., Cai W., Huang Q., Mesenchymal stem cells alleviate bacteria-induced liver injury in mice by inducing regulatory dendritic cells. Hepatology 2014 59 2 671 682 10.1002/hep.26670
105. Han Z., Jing Y., Zhang S., The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth. Cell & Bioscience 2012 2 1, article 8 10.1186/2045-3701-2-8
106. Tian H., Lu Y., Shah S. P., Wang Q., Hong S., 14S,21 R -dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury. Stem Cells and Development 2012 21 7 1187 1199 2-s2.0-84860137826 10.1089/scd.2011.0220
107. Kronsteiner B., Peterbauer-Scherb A., Grillari-Voglauer R., Redl H., Gabriel C., van Griensven M., Wolbank S., Human mesenchymal stem cells and renal tubular epithelial cells differentially influence monocyte-derived dendritic cell differentiation and maturation. Cellular Immunology 2011 267 1 30 38 2-s2.0-78651060858 10.1016/j.cellimm.2010.11.001
108. Spaggiari G. M., Abdelrazik H., Becchetti F., Moretta L., MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 2009 113 26 6576 6583 2-s2.0-69249227552 10.1182/blood-2009-02-203943
109. Ratajczak J., Miekus K., Kucia M., Zhang J., Reca R., Dvorak P., Ratajczak M. Z., Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006 20 5 847 856 2-s2.0-33646146422 10.1038/sj.leu.2404132
110. Camussi G., Deregibus M. C., Bruno S., Cantaluppi V., Biancone L., Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney International 2010 78 9 838 848 2-s2.0-77958098024 10.1038/ki.2010.278
111. Camussi G., Deregibus M. C., Cantaluppi V., Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochemical Society Transactions 2013 41 1 283 287 10.1042/BST20120192
112. Wu S., Ju G. Q., Du T., Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo. PLoS ONE 2013 8 4, article e61366 10.1371/journal.pone. 0061366
113. Polgar J., Matuskova J., Wagner D. D., The P-selectin, tissue factor, coagulation triad. Journal of Thrombosis and Haemostasis 2005 3 8 1590 1596 2-s2.0-28344441333 10.1111/j.1538-7836.2005.01373.x (Pubitemid 41716543)
114. Kim J. W., Wieckowski E., Taylor D. D., Reichert T. E., Watkins S., Whiteside T. L., Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clinical Cancer Research 2005 11 3 1010 1020 2-s2.0-12944329896 (Pubitemid 40175748)
115. Ratajczak J., Wysoczynski M., Hayek F., Janowska-Wieczorek A., Ratajczak M. Z., Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006 20 9 1487 1495 2-s2.0-33747616431 10.1038/sj.leu.2404296 (Pubitemid 44264090)
116. Collino F., Deregibus M. C., Bruno S., Sterpone L., Aghemo G., Viltono L., Tetta C., Camussi G., Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 2010 5 7, article e11803 2-s2.0-77955643809 10.1371/journal.pone.0011803
117. Valadi H., Ekstrom K., Bossios A., Sjöstrand M., Lee J. J., Lötvall J. O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007 9 6 654 659 2-s2.0-34249302620 10.1038/ncb1596 (Pubitemid 47214727)
118. Ramachandran S., Palanisamy V., Horizontal transfer of RNAs: exosomes as mediators of intercellular communication. Wiley Interdisciplinary Reviews: RNA 2012 3 2 286 293 10.1002/wrna.115
119. Nolte-'t Hoen E. N., Buschow S. I., Anderton S. M., Stoorvogel W., Wauben M. H. M., Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood 2009 113 9 1977 1981 2-s2.0-61849179182 10.1182/blood-2008-08- 174094
120. Sheldon H., Heikamp E., Turley H., Dragovic R., Thomas P., Oon C. E., Leek R., Edelmann M., Kessler B., Sainson R. C. A., Sargent I., Li J.-L., Harris A. L., New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 2010 116 13 2385 2394 2-s2.0-77957708340 10.1182/blood-2009-08-239228
121. Bruno S., Grange C., Deregibus M. C., Calogero R. A., Saviozzi S., Collino F., Morando L., Busca A., Falda M., Bussolati B., Tetta C., Camussi G., Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. Journal of the American Society of Nephrology 2009 20 5 1053 1067 2-s2.0-65649089130 10.1681/ASN.2008070798
122. Bruno S., Grange C., Collino F., Deregibus M. C., Cantaluppi V., Biancone L., Tetta C., Camussi G., Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS ONE 2012 7 3, article e33115 2-s2.0-84858185865 10.1371/journal.pone.0033115
123. Zhou Y., Xu H., Xu W., Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Research & Therapy 2013 4 2, article 34 10.1186/scrt194
124. Gatti S., Bruno S., Deregibus M. C., Sordi A., Cantaluppi V., Tetta C., Camussi G., Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrology Dialysis Transplantation 2011 26 5 1474 1483 2-s2.0-79955571241 10.1093/ndt/gfr015